Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India flag India · Delayed Price · Currency is INR
669.90
-4.40 (-0.65%)
Jul 31, 2026, 3:30 PM IST

Aarti Pharmalabs Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,7472,7242,1691,9351,223
Depreciation & Amortization
1,043816.44719.65625.43421.19
Other Amortization
-52.612.7--
Loss (Gain) From Sale of Assets
---5.514.47-0.4
Asset Writedown & Restructuring Costs
71.44----
Stock-Based Compensation
24.76----
Provision & Write-off of Bad Debts
22.5412.8110.6815-
Other Operating Activities
779.73570.38475.51237.64223.3
Change in Accounts Receivable
-992.77-844.33-1,255-351.72-1,025
Change in Inventory
-805.65552.79-396.64-1,267-559.92
Change in Accounts Payable
702.46-569.13433.481,302-718.62
Change in Other Net Operating Assets
26.37----
Operating Cash Flow
2,6193,3162,1642,501-437.04
Operating Cash Flow Growth
-21.00%53.25%-13.50%--

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-4,094-4,020-1,556-1,021-1,412
Sale (Purchase) of Intangibles
389.47-418.41-431.81-175.29-
Investment in Securities
125.12228.34-188.53-391.23-0.73
Other Investing Activities
-728.0971.4730.749.7724.86
Investing Cash Flow
-4,307-4,139-2,146-1,578-1,387

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
1,578278.61499.94-2,723
Long-Term Debt Issued
1,0641,000---
Total Debt Issued
2,6421,279499.94-2,723
Short-Term Debt Repaid
----1,243-
Long-Term Debt Repaid
-186.82-62-49.3--
Total Debt Repaid
-186.82-62-49.3-1,243-
Net Debt Issued (Repaid)
2,4561,217450.64-1,2432,723
Issuance of Common Stock
0.120.04---
Common Dividends Paid
-362.59-317.19-181.25-181.25-
Other Financing Activities
-387.35-245.12-172.15-210.52-119.59
Financing Cash Flow
1,706654.3597.24-1,6352,604

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
--0--
Net Cash Flow
17.97-169.01115.14-711.52779.41

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-1,474-704.76607.51,480-1,849
Free Cash Flow Growth
---58.95%--
Free Cash Flow Margin
-8.10%-3.33%3.28%7.61%-15.40%
Free Cash Flow Per Share
-16.25-7.776.7016.33-20.40
Levered Free Cash Flow
-1,659-2,176-521.96940.76-6,998
Unlevered Free Cash Flow
-1,366-2,008-414.371,072-6,995

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
387.35245.12172.15210.523.4
Cash Income Tax Paid
469.27645.27569.37623.83211.29
Change in Working Capital
-1,070-860.66-1,219-316.32-2,304